Trevi Therapeutics, Inc. (TRVI) Earnings Per Share, Basic USD/shares 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Trevi Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2024.
  • Trevi Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.11 USD/shares, a 83.3% decline year-over-year.
  • Trevi Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -0.34 USD/shares, a 25.9% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.29 USD/shares, a 35.6% increase from 2022.
  • Trevi Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.45 USD/shares, a 69.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 $0 -83.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $0 $0 $0 -260% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $0 $0 +$0.04 +33.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $0 $0 +$0.07 +50% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $0 $0 +$0.18 +75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $0 $0.05 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $0 +$0.22 +64.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 +$0.35 +71.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.